I use an LG 27-inch 4K monitor, a pair of PreSonus Eris E8 XT studio monitors, Beyerdynamic and Sennheiser studio headphones, and a Focusrite audio interface. My amazing wife is a film and ...

TORONTO--(BUSINESS WIRE)--EDR and ERIS have announced the resolution of their dispute and lawsuit involving EDR’s claims of copyright infringement and ERIS’s claims of antitrust violations ...

Indian drugmakers Biocon, Eris Lifesciences, and Wockhardt are ramping up insulin production to capture a growing global opportunity, as market leader Novo Nordisk scales back its presence in ...

Eris Lifesciences Limited was incorporated on January 25, 2007. Subsequently, the name of the company was changed to Eris Lifesciences Private Limited on February 9, 2007. Further, the Company was ...

Eris Lifesciences, operating in the Pharmaceuticals sector and classified as a Midcap on the BSE, currently has its share price at ₹1783.5. The stock has experienced fluctuations today, with a ...

Eris Lifesciences share price gained 4.2 per cent in trade, logging an intraday high at ₹1,504.5 per share on BSE. The buying on the counter came after the company posted its Q4 results. The company ...

Eris Lifesciences added 1.22% to Rs 1,461 after the company's consolidated net profit jumped 32.1% to Rs 93.84 crore on 28.4% increase in revenue from operations to Rs 702.60 crore in Q4 FY25 over Q4 ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

Eris Lifesciences Ltd., incorporated in the year 2007, is a Mid Cap company (having a market cap of Rs 24,437.89 Crore) operating in Pharmaceuticals sector. Eris Lifesciences Ltd. key Products/Revenue ...